MOESM2 of Epidemiology and prognosis of anti-infective therapy in the ICU setting during acute pancreatitis: a cohort study

Montravers, Philippe; Kantor, Elie; Constantin, Jean-Michel; Lefrant, Jean-Yves; Lescot, Thomas; Nesseler, Nicolas; Paugam, Catherine; Jabaudon, Matthieu; Dupont, HervÃ©

doi:10.6084/m9.figshare.11329331.v1

13054_2019_2681_MOESM2_ESM.pptx (92.38 kB)

MOESM2 of Epidemiology and prognosis of anti-infective therapy in the ICU setting during acute pancreatitis: a cohort study

presentation

posted on 2019-12-06, 04:44 authored by Philippe Montravers, Elie Kantor, Jean-Michel Constantin, Jean-Yves Lefrant, Thomas Lescot, Nicolas Nesseler, Catherine Paugam, Matthieu Jabaudon, HervÃ© Dupont

Additional file 2: Figure S4. Proportions (expressed per centre) of patients who underwent endoscopic (panel A), surgical (B), percutaneous (C) or no therapeutic intervention (D) between Day>0 and Day30.